Canadian Non-Interventional Study of Xeljanz in Rheumatoid Arthritis (CANTORAL)

26/10/2017
22/02/2024
EU PAS number:
EUPAS21413
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

A3921280_FINAL PROTOCOL V1.1_02OCT2017

English (378.03 KB - PDF) View document
Updated protocol

A3921280 Protocol Amendment 4 19Jan2022

First published: 22/02/2024
English (2.11 MB - PDF) View document
Study results
Study results

A3921280 Non Interventional Study Report Abstract 01 May 2023_Redacted

English (1.91 MB - PDF) View document
Study report
Study report

A3921280 Non Interventional Study Report 01 May 2023_Redacted (2)

English (5.86 MB - PDF) View document
Other information
Study, other information

A3921280_NON-INTERVENTIONAL STUDY ABSTRACT v4.0_19Jan2022

English (1.76 MB - PDF) View document